News

ERN training Workshop in Turku: COMPREHENSIVE GENE PROFILING, MOLECULAR TUMOR BOARD (MTB) AND ARTIFICIAL INTELLIGENCE IN THE DIAGNOSIS AND TREATMENT OF PATIENTS WITH RARE ADULT CANCERS

Cancer and Extracellular Vesicles Summer School 1.-2.6.2022, organized by Insitute of Biomedicine & Cancer Research Community, UEF

SAVE THE DATE: iCAN-FCI Cancer Symposium, September 22-23, Helsinki

Symposium “Cutting-Edge Implementation of Precision Medicine in Europe” in Karolinska Institutet, Stockholm, Sep 22-23, 2022

iCAN receives 14 million euro grant to promote development of personalized treatments for cancer

Cancer IO Training “Translating research into clinical benefit” in January 2022

SNOG – FiBTRA Symposium, Paja Congress Center Tampere 19-21.5.2022

FICAN South announces a call for applications for project funding 2022

FICAN (Comprehensive Cancer Center Finland) and its coordinating unit, is seeking a DIRECTOR OF THE FINNISH CANCER CENTER

The Finnish Cancer Institute invites applications for Two 2-year postdoctoral cancer researcher positions

The HERCULES EU project organizes its final webinar on June 14, 2021: Clinical Importance of Drug Resistance Mechanisms in Ovarian Cancer

Cancer – Breaking Bad Symposium at BioCity Turku, Finland 19-20 August 2021

A master cancer gene hijacks a “molecular crowbar” to make breast cancer cells invasive

Mapping the immune landscape of haematological cancers may help to enhance therapies

10 million euros investment boosts Finnish capabilities in cancer immunotherapy

Closing seminar of the 2019 Scientific Research and Development projects 23.01.2020 at 1-4 pm., Terkko Health Hub Event square, Meilahti

Mika Mustonen new Director of FICAN South

The Finnish Cancer Institute has opened nine research positions, FCI-deadline Sept. 12

Digital health to support precision cancer medicine in ican – a new academy of finland flagship

HUS Comprehensive Cancer Center and Pfizer begin a partnership to promote clinical trials for cancer drugs